Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 14/20 | 0.52 |
| ▸ | SLC16A1 | P53985 | 13/20 | 0.52 |
| ▸ | MCTS1 | Q9ULC4 | 9/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.43 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18307410 | 0.82 | SLC16A3 (0.60) | SLC16A3SLC16A1MCTS1MEN1NPC1 | |
| SCHEMBL31130272 | 0.81 | SLC16A3 (0.52) | SLC16A3SLC16A1MCTS1 | |
| SCHEMBL29819644 | 0.80 | SLC16A3 (0.70) | SLC16A3SLC16A1MCTS1 | |
| SCHEMBL20239471 | 0.80 | SLC16A3 (0.70) | SLC16A3SLC16A1MCTS1 | |
| SCHEMBL8364695 | 0.79 | LMNA (0.44) | SLC16A3SLC16A1MCTS1NPC1RAB9A | |
| SCHEMBL20239517 | 0.78 | SLC16A3 (0.63) | SLC16A3SLC16A1MCTS1MEN1NPC1 | |
| SCHEMBL29819639 | 0.78 | SLC16A3 (0.63) | SLC16A3SLC16A1MCTS1MEN1NPC1 | |
| SCHEMBL31130145 | 0.78 | SLC16A3 (0.63) | SLC16A3SLC16A1MCTS1MEN1NPC1 | |
| SCHEMBL20239564 | 0.78 | SLC16A3 (0.80) | SLC16A3SLC16A1MCTS1 | |
| SCHEMBL20239469 | 0.77 | SLC16A3 (0.63) | SLC16A3SLC16A1MCTS1MEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4442318-A2 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC (US) | 2024-10-09 | — | — | EP | disclosed |